Shoibal is the Head of the Digital Strategy Group within the Data Sciences Institute at Takeda. In support of Takeda's commitment to digital and data he is responsible for working with colleagues across the enterprise to develop patient-centric digital strategies for the development of novel endpoints and make studies more resilient through decentralized approaches. Prior to this Shoibal was Vice President of PPD Digital where he was responsible for setting the strategy and working with external platform partners and device manufacturers to devise compliant, globally scalable approaches to conduct decentralized trials and to oversee the integration of the technologies into conventional clinical research and data management processes. Prior to that, he spent 13 years at Biogen in a range of roles in translational informatics, data sciences and as part of an innovation hub that launched MS PATHS, a learning healthcare system that utilises technology to capture high quality data as standard of care for over 10,000 MS patients globally supporting RWE and value-based medicine initiatives.